DPP4 inhibitor requiring dose reduction in both liver and kidney failure: (A) Linagliptin, (B) Sitagliptin, (C) Saxagliptin, (D) Vildagliptin
Answer is D. Vildagliptin require and of both reductions in liver and kidney failure.Ref: KDT 7TH/275